Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to
US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court
The cryptocurrency market opened the new weekly candle bearish, as Bitcoin, Ether, and XRP tested key support levels. Ether, the second-largest cryptocurrency by
In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of a financial future
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.